Expleo Solutions [EXPLEOSOL] vs Cigniti Technologies [CIGNITITEC] Detailed Stock Comparison
Expleo Solutions
NSE
Loading...
Cigniti Technologies
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Expleo Solutions wins in 7 metrics, Cigniti Technologies wins in 12 metrics, with 0 ties. Cigniti Technologies appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Expleo Solutions | Cigniti Technologies | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 15.29 | 16.30 | Expleo Solutions |
| Price-to-Book Ratio | 2.40 | 4.33 | Expleo Solutions |
| Debt-to-Equity Ratio | 4.69 | 2.90 | Cigniti Technologies |
| PEG Ratio | -1.05 | 0.03 | Expleo Solutions |
| EV/EBITDA | 8.66 | 11.41 | Expleo Solutions |
| Profit Margin (TTM) | 9.67% | 12.29% | Cigniti Technologies |
| Operating Margin (TTM) | 8.88% | 15.24% | Cigniti Technologies |
| EBITDA Margin (TTM) | 8.88% | 15.24% | Cigniti Technologies |
| Return on Equity | 16.24% | 20.78% | Cigniti Technologies |
| Return on Assets (TTM) | 12.42% | 16.15% | Cigniti Technologies |
| Free Cash Flow (TTM) | $1.72B | $1.46B | Expleo Solutions |
| Dividend Yield | 3.87% | N/A | N/A |
| 1-Year Return | -21.43% | 10.24% | Cigniti Technologies |
| Price-to-Sales Ratio (TTM) | 1.48 | 2.00 | Expleo Solutions |
| Enterprise Value | $13.37B | $37.97B | Cigniti Technologies |
| EV/Revenue Ratio | 1.30 | 1.83 | Expleo Solutions |
| Gross Profit Margin (TTM) | 35.93% | 44.53% | Cigniti Technologies |
| Revenue per Share (TTM) | $665 | $754 | Cigniti Technologies |
| Earnings per Share (Diluted) | $64.27 | $92.86 | Cigniti Technologies |
| Beta (Stock Volatility) | -0.05 | -0.24 | Cigniti Technologies |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Expleo Solutions vs Cigniti Technologies Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Expleo Solutions | 2.16% | 3.42% | -2.46% | -24.64% | 22.06% | -27.50% |
| Cigniti Technologies | 0.90% | 4.56% | -6.65% | -15.53% | 15.37% | -12.35% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Expleo Solutions | -21.43% | -19.21% | 94.30% | 69.65% | 747.74% | 347.78% |
| Cigniti Technologies | 10.24% | 182.56% | 223.16% | 240.35% | 226.17% | 226.17% |
News Based Sentiment: Expleo Solutions vs Cigniti Technologies
Expleo Solutions
News based Sentiment: MIXED
September brought a mixed bag for Expleo Solutions, with moderate revenue growth in Q1 FY26 offset by declining EBITDA margins. While analyst optimism and expansion into Saudi Arabia offer potential, current market challenges and a slight dip in EPS create a complex investment picture.
Cigniti Technologies
News based Sentiment: POSITIVE
Cigniti Technologies delivered impressive financial results in Q1 FY26 and for the full fiscal year 2025-26, demonstrating strong growth and profitability. While the potential merger with Coforge Limited adds a layer of uncertainty, the company's solid performance and attractive valuation metrics make it a compelling investment opportunity.
Performance & Financial Health Analysis: Expleo Solutions vs Cigniti Technologies
| Metric | EXPLEOSOL | CIGNITITEC |
|---|---|---|
| Market Information | ||
| Market Cap | ₹15.72B | ₹43.11B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 10,348 | 69,112 |
| 90 Day Avg. Volume | 18,493 | 65,557 |
| Last Close | ₹1,004.15 | ₹1,528.40 |
| 52 Week Range | ₹735.35 - ₹1,567.45 | ₹1,033.25 - ₹1,970.00 |
| % from 52W High | -35.94% | -22.42% |
| All-Time High | ₹1,874.00 (Jan 03, 2022) | ₹1,970.00 (Dec 16, 2024) |
| % from All-Time High | -46.42% | -22.42% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.03% | 0.14% |
| Quarterly Earnings Growth | -0.15% | 5.27% |
| Financial Health | ||
| Profit Margin (TTM) | 0.10% | 0.12% |
| Operating Margin (TTM) | 0.09% | 0.15% |
| Return on Equity (TTM) | 0.16% | 0.21% |
| Debt to Equity (MRQ) | 4.69 | 2.90 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹409.70 | ₹349.61 |
| Cash per Share (MRQ) | ₹140.46 | ₹145.45 |
| Operating Cash Flow (TTM) | ₹1.27B | ₹974.04M |
| Levered Free Cash Flow (TTM) | ₹1.03B | ₹2.00B |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.87% | N/A |
| Last 12-Month Dividend | ₹50.00 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Expleo Solutions vs Cigniti Technologies
| Metric | EXPLEOSOL | CIGNITITEC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 15.29 | 16.30 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -1.05 | 0.03 |
| Price to Sales (TTM) | 1.48 | 2.00 |
| Price to Book (MRQ) | 2.40 | 4.33 |
| Market Capitalization | ||
| Market Capitalization | ₹15.72B | ₹43.11B |
| Enterprise Value | ₹13.37B | ₹37.97B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.30 | 1.83 |
| Enterprise to EBITDA | 8.66 | 11.41 |
| Risk & Other Metrics | ||
| Beta | -0.05 | -0.24 |
| Book Value per Share (MRQ) | ₹409.70 | ₹349.61 |
Financial Statements Comparison: Expleo Solutions vs Cigniti Technologies
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EXPLEOSOL | CIGNITITEC |
|---|---|---|
| Revenue/Sales | ₹2.60B | ₹5.34B |
| Cost of Goods Sold | ₹1.66B | ₹2.96B |
| Gross Profit | ₹932.96M | ₹2.38B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹220.52M | ₹814.00M |
| EBITDA | ₹366.69M | ₹972.00M |
| Pre-Tax Income | ₹283.56M | ₹889.00M |
| Income Tax | ₹79.31M | ₹230.00M |
| Net Income (Profit) | ₹204.25M | ₹659.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EXPLEOSOL | CIGNITITEC |
|---|---|---|
| Cash & Equivalents | ₹2.17B | ₹1.99B |
| Total Current Assets | ₹5.63B | ₹10.94B |
| Total Current Liabilities | ₹1.44B | ₹2.49B |
| Long-Term Debt | ₹221.44M | ₹132.35M |
| Total Shareholders Equity | ₹6.36B | ₹9.63B |
| Retained Earnings | ₹7.15B | ₹6.58B |
| Property, Plant & Equipment | ₹1.01B | ₹68.79M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EXPLEOSOL | CIGNITITEC |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | EXPLEOSOL | CIGNITITEC |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 10,348 | 69,112 |
| Average Daily Volume (90 Day) | 18,493 | 65,557 |
| Shares Outstanding | 15.52M | 27.30M |
| Float Shares | 4.41M | 10.17M |
| % Held by Insiders | 0.71% | 0.75% |
| % Held by Institutions | 0.00% | 0.11% |
Dividend Analysis & Yield Comparison: Expleo Solutions vs Cigniti Technologies
| Metric | EXPLEOSOL | CIGNITITEC |
|---|---|---|
| Last 12-Month Dividend | ₹50.00 | ₹0.00 |
| Last 12-Month Dividend Yield | 3.87% | N/A |
| 3-Year Avg Annual Dividend | ₹18.33 | ₹2.00 |
| 3-Year Avg Dividend Yield | 2.61% | 0.32% |
| 3-Year Total Dividends | ₹55.00 | ₹6.00 |
| Ex-Dividend Date | Feb 12, 2025 | Nov 16, 2023 |